An autonomous testing platform focused on improving software reliability by automatically finding bugs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Antithesis is an autonomous testing platform focused on improving software reliability by automatically finding bugs and ensuring perfect reproducibility for debugging and resolution.
Antithesis Funding
Sign up to gain insights into Antithesis funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A-1 | Dec 03, 2025 | 75M | ||
| Series A-2 | Dec 03, 2025 | 30M | ||
| Series 3 | Feb 13, 2024 | 31M | ||
| Series 2 | Feb 13, 2024 | 15M | ||
| Series 1 | Feb 13, 2024 | 1M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Antithesis Management Team
Investors
Amplify Partners LP
Dwarkesh Patel
First In Ventures
Hyperion Partners
Jane Street
Patrick Collison
Sholto Douglas
Spark Capital
Tamarack Global
Teamworthy Ventures
Antithesis Valuations & Financials
View real-time NPM data on Antithesis stock including daily Antithesis stock price estimates, valuation history, and historical share price information. Access Antithesis financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Antithesis pricing across six independent market signals. Looking for private company due diligence data sources on Antithesis? Get in touch to learn more.
Similar Companies
like Antithesis
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Outreach
Enterprise Software
Sales communication platform, delivering a sales automation tool for SMB and enterprise organizations.
Juniper Square
Enterprise Software
Software streamlining fundraising, investment administration, and investor reporting for the private funds industry.
RelationalAI
Enterprise Software
Next-generation database platform for AI-driven applications.
Webflow
Enterprise Software
Offers a no-code platform for designing, building, and hosting responsive websites, enabling users to create professional web experiences.
MindTickle
Enterprise Software
Enhances sales teams with learning and analytics tools that strengthen preparedness and elevate performance in customer engagements.
Mural
Enterprise Software
Digital visual collaboration platform providing virtual whiteboards for teams to brainstorm, plan and organize ideas together online.
Collibra
Enterprise Software
Cloud platform delivering enterprise-wide data intelligence through unified governance, quality management, and privacy controls.
FAQ
We have answers
Antithesis stock does not trade on public stock exchanges. Antithesis stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Antithesis stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Antithesis Stock does not trade on public stock exchanges. In order to sell Antithesis shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Antithesis does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Antithesis share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Antithesis stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Antithesis stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Antithesis stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Antithesis is a private company and has not had an IPO. There is currently no Antithesis IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Antithesis IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
